-+ 0.00%
-+ 0.00%
-+ 0.00%

MEDICUS PHARMA LTD ANNOUNCES SUBMISSION OF PHASE 2 CLINICAL DESIGN (SKNJCT-004) TO UNITED ARAB EMIRATES (UAE) DEPARTMENT OF HEALTH (DOH) TO NON-INVASIVELY TREAT BASAL CELL CARCINOMA OF THE SKIN (BCC)

Reuters·02/27/2025 12:31:34

Please log in to view news